Pay in installments of $6.77 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
More data on Retatrutide dropped today at the ADA conference!! Reta is an investigational not FDA approved yet once weekly medication that simultaneously activates the GIP, GLP 1, and glucagon receptors In the Phase Comparing the Big 3, Semaglutide, Tirzepatide and Retatrutide : r Mounjaro GLP 1 Patches 30 Patches Perfect Patches GLP 1 and Microbiome Repair for Long Term Metabolism
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.1 ★★★★★
Based on 18 reviews
Sort
Product Reviews
★★★★★ 5
Love Ordinary brand skincare products!!
I love the Ordinary brand of skin products. This particular product works great and got it for a good price!!!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 30, 2026
★★★★★ 5
Excelente
Muy buena 100%
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 7, 2026
★★★★★ 5
👏🏻
Awesome
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 4, 2026
★★★★★ 2
Not for me
Did not work for me and after a week my skin was more oily and break outs were bad. I feel as though this brand should be ment for teenagers
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 8, 2025
★★★★★ 1
Not as described
Not as described. Doesn't do anything for me
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 9, 2025